Background-Intimal hyperplasia contributes to restenosis after percutaneous vascular interventions. Both ␤ 3 -integrins, ␣ V ␤ 3 and ␣ IIb ␤ 3 (glycoprotein IIb/IIIa), and leukocytes have been implicated in neointimal formation, based in part on the results obtained using antagonists to 1 or both receptors in animal models. Methods and Results-The responses in wild-type mice, ␤ 3 -integrin-deficient mice, and P-selectin-deficient mice were studied in a model of transluminal endothelial injury of the femoral artery. At 4 weeks, ␤ 3 -integrin-deficient mice were not protected from developing intimal hyperplasia, whereas P-selectin-deficient mice were protected. Within 1 hour of injury, several layers of platelets deposited on the arteries of wild-type mice and a single layer of platelets deposited on the vessels of ␤ 3 -integrin-deficient mice; in both cases, leukocytes were recruited to the platelet layer. In P-selectin-deficient mice, the platelet layer was less compact and extended further into the lumen but did not recruit leukocytes.
P ercutaneous coronary interventions are increasingly being used to treat acute coronary syndromes, with an estimated 926 000 procedures performed in the United States in 1998. 1 Despite improvements in technique, as well as the use of stents and new antiplatelet therapies, restenosis requiring repeat procedures continues to be an important complication, affecting Ϸ8% of patients at 6 months, even with optimal treatment. 2 Because intimal hyperplasia contributes to restenosis after vascular injury, 3 understanding the molecular mechanisms involved in its development is particularly important. It is well established that platelet deposition and leukocyte recruitment occur soon after vascular damage, 4 but their contributions, if any, to the subsequent smooth muscle cell proliferation and migration that result in intimal hyperplasia remain unclear.
There is reason to hypothesize that both of the ␤ 3containing integrins, ␣ IIb ␤ 3 (glycoprotein [GP] IIb/IIIa), which is platelet specific, 5 and ␣ V ␤ 3 , which is present on endothelial cells and smooth muscle cells in addition to other cells, 6 play important roles in the development of intimal hyperplasia after vascular injury. Thus, ␣ IIb ␤ 3 is necessary for platelet aggregation induced by physiological agonists, con-tributes to platelet-mediated thrombin generation, and facilitates release of platelet mediators (platelet-derived growth factor, serotonin, and ADP) 4, 7, 8 that may promote smooth muscle cell proliferation and/or migration. Similarly, a number of in vitro and in vivo studies implicate ␣ V ␤ 3 in smooth muscle cell proliferation and migration. 6,9 -11 In fact, antagonists to ␣ V ␤ 3 or to both ␣ IIb ␤ 3 and ␣ V ␤ 3 significantly inhibited intimal hyperplasia after vascular injury in all but 1 of a large number of animal studies (Table 1) . Given the wealth of theoretical and experimental data implicating ␤ 3 -integrins in intimal hyperplasia, we sought to determine whether ␤ 3integrin null mice (␤ 3 Ϫ/Ϫ), which lack both ␣ IIb ␤ 3 and ␣ V ␤ 3 , are protected from developing intimal hyperplasia after vascular injury. Because leukocyte recruitment mediated by P-selectin has also been implicated in facilitating intimal hyperplasia after vascular injury in mice 12 and, recently, in rats, 13 we also studied P-selectin null mice (P-selectinϪ/Ϫ).
Methods

Animals
The generation of ␤ 3 -integrin-deficient mice by homologous recombination in embryonic stem cells and their phenotype have been described previously. 14 Wild-type (␤ 3 ϩ/ϩ) and ␤ 3 Ϫ/Ϫ mice were descendants of F2 intercrosses and therefore had a mixed genetic background of C57Bl/6 and 129Sv strains. P-selectin-deficient mice backcrossed on the C57Bl/6 strain were obtained from Jackson Laboratories (Bar Harbor, Maine). Wild-type C57Bl/6 and 129Sv mice (Jackson Laboratories) served as controls for the effect of genetic background on the response to arterial injury. Mice were maintained on 12-hour light/12-hour dark cycles, fed standard rodent chow (5001; Purina Mills), and provided with water ad libitum. All procedures conformed to the recommendations of the Guide for the Care and Use of Laboratory Animals (Department of Health, Education, and Welfare publication number NIH 78- 23, 1996) and were approved by the Mount Sinai Institutional Animal Care and Use Committee.
Arterial Injury
Male mice aged 8 to 10 weeks were anesthetized with inhaled isoflurane, and wire injury of the femoral artery was performed as described previously. 15, 16 In brief, the femoral vessels were exposed by a longitudinal groin incision and viewed with the aid of a surgical microscope (Carl Zeiss). The distal portion of the femoral artery was encircled with an 8-0 nylon suture, a vascular clamp was placed proximally at the level of the inguinal ligament, and a 0.010-in (0.25-mm) diameter angioplasty guidewire (Advanced Cardiovascular Systems) was introduced into the arterial lumen through an arteriotomy made just distal to the suture. After release of the clamp, the guidewire was advanced to the level of the aortic bifurcation and immediately pulled back; this process was repeated 2 additional times to denude the endothelium. The guidewire was then removed, and the arteriotomy site was ligated by tying the previously placed suture. In a previous study, 15 we demonstrated that sham-operated mice that undergo all maneuvers (dissection, vascular clamping, arteriotomy, and ligation) except passage of the guidewire display no evidence of damage to the vessel wall and no vascular reaction. The injury results in Ͼ99% endothelial denudation, as judged by morphological and immunohistochemical analysis with antibodies to von Willebrand factor 15 and intercellular adhesion molecule-1 (data not shown), and Ͻ2% laceration of the internal elastic lamina (IEL).
Histology and Morphometry
Mice were killed 1 hour or 4 weeks after injury by perfusion fixation with 4% paraformaldehyde in PBS, pH 7.4 at 100 mm Hg for 5 minutes, administered via a cannula inserted in the left ventricle. Hindlimbs were excised en bloc, fixed in 4% paraformaldehyde in PBS for 24 hours, and decalcified in 10% formic acid overnight. Each limb was cut transversely, dividing the common femoral artery into 2 segments, each of which was 2 mm in length. Each segment was embedded in paraffin. Sections (5 m) were obtained for staining or immunohistochemistry. Combined Mason-elastic stain was used for measurements of the arterial wall layers. Sections were analyzed by computerized morphometry and the different regions of the vessel quantified with Image Pro Plus software. Measurements of luminal area, area inside the IEL, and area beneath the external elastic lamina were made on each section. Intimal area was calculated by subtracting luminal area from the area inside the IEL; medial area was calculated by subtracting the area inside the IEL from the area inside the external elastic lamina. Results from the 2 segments of each artery were averaged.
For immunohistochemical analysis, sections were deparaffinized, rinsed in xylene, rehydrated, and then blocked first with 3% hydrogen peroxide and then with 2% ovalbumin in PBS. The sections were incubated at 37°C with primary antibodies, followed by biotin-conjugated secondary antibodies (Biogenics). Staining was detected by reaction with horseradish peroxidase-streptavidin and diaminobenzidine; sections were counterstained with hematoxylin. Rabbit polyclonal anti-mouse platelet antibody was from Inner Cell Technologies; polyclonal anti-P-selectin antibody was from Pharmingen; polyclonal anti-von Willebrand factor antibody was from Dako; and polyclonal anti-fibrinogen antibody was from Behring.
Electron Microscopy
Animals (␤ 3 ϩ/ϩ, nϭ4; ␤ 3 Ϫ/Ϫ, nϭ4; P-selectinϪ/Ϫ, nϭ2; C57Bl/6, nϭ2) underwent the standard vascular injury procedure and were euthanized by perfusion fixation. With the aid of the surgical microscope, a segment of the common femoral artery (from the takeoff of the epigastric artery to the inguinal ligament) was dissected. The isolated artery was immersed in 2% paraformaldehyde/2.5% glutaraldehyde in 0.1 mol/L cacodylate buffer and, after fixation, transected in the center; 2-m cross sections for transmission electron microscopy (TEM) were obtained and then the remaining halves of the artery were cut longitudinally to expose the lumen for scanning electron microscopy (SEM). For TEM, the arteries were dehydrated in graded alcohols, embedded in EMbed 812 (Electron Microscopy Sciences), and thin sectioned. The sections were stained with uranyl acetate and lead citrate and then viewed with a JEM 100 CX microscope (JEOL Ltd). For SEM, the longitudinal sections were critical-point dried, mounted in silver paint, coated with goldpalladium, and examined in a Hitachi S350 microscope. For statistical analysis, a blinded investigator selected 8 representative images of platelet thrombi from each of 4 separate arteries per group. The number of granules and platelets per micrometer of IEL was obtained from digitized images.
Statistical Analysis
Results are expressed as meanϮSD, unless otherwise indicated. Comparisons were made between C57/129 wild-type and ␤ 3 Ϫ/Ϫ mice and between C57Bl/6 wild-type and P-selectinϪ/Ϫ mice by Mann-Whitney U test. 
Results
Early Platelet Deposition and Leukocyte Recruitment After Endothelial Denudation of the Femoral Artery
One hour after guidewire-induced endothelial denudation of the femoral arteries of wild-type C57Bl/6 and mixed C57/ 129Sv mice, platelets were found adherent to the blood vessel wall and leukocytes were found to adhere to the platelets (Figures 1 and 2 ). Platelets were identified by both TEM and SEM. The platelet layer varied between 1 and Ϸ3 platelets thick when viewed by TEM ( Figure 1A) , and many of the platelets in contact with the vessel were spread and at least partially degranulated. SEM observations were consistent with the TEM data, with platelets forming a nearly continuous layer ( Figure 1B) ; in only a few areas, platelet thrombus formation extended from the surface into the lumen. Immunohistochemistry also demonstrated a platelet layer, with positive reactions with polyclonal antibodies to whole mouse platelets ( Figure 2C ), as well as plateletassociated proteins (P-selectin, fibrinogen, and von Willebrand factor; data not shown). Leukocytes were readily identified attached to the luminal surface of the adherent platelets by both electron microscopy ( Figure 1A and 1B) and light microscopy (Figure 2A) . In ␤ 3 -null animals, the platelet layer appeared to be restricted to only a monolayer of platelets, many of which were extensively spread along the surface, with few plateletplatelet interactions ( Figure 1C through 1E) . Leukocytes were readily observed attached to the platelets, however ( Figures  1C, 1E, and 2B) , and there was no significant difference in the number of leukocytes attached to platelets in the ␤ 3 Ϫ/Ϫ mice compared with the wild-type mice (Figure 2A versus 2B; 60Ϯ20% of the circumference of the ␤ 3 ϩ/ϩ arteries versus 60Ϯ30% of the ␤ 3 Ϫ/Ϫ arteries had attached leukocytes).
One hour after vascular injury to the femoral arteries of P-selectinϪ/Ϫ mice, TEM revealed a platelet layer several platelets thick that extended from the surface of the blood vessel ( Figure 3A through 3C ; Table 2 ). In contrast to the results with wild-type mice, the platelet layer appeared less compact, and more of the platelets retained their granules (Figure 3A through 3C; Table 2 ). By SEM, the platelets in the P-selectinϪ/Ϫ mice ( Figure 3D and 3E) appeared to extend further out from the vessel surface than did platelets in the wild-type mice ( Figure 1B ; Table 2 ). In sharp contrast to the results with wild-type and ␤ 3 Ϫ/Ϫ mice, there was a striking decrease in leukocyte attachment to the platelets of P-selec-tinϪ/Ϫ mice ( Figure 2D ; 50Ϯ30% of the circumference of the C57B/l6 wild-type arteries had attached leukocytes versus Ͻ5% of the circumference of P-selectinϪ/Ϫ arteries).
Intimal Hyperplasia at 4 Weeks
Because strain differences have been reported to affect neointimal development in response to vascular injury in other models, [17] [18] [19] we studied separately wild-type C57Bl/6, wild-type 129Sv, and mixed C57/129Sv mice. In accord with results published by others, we found that the wild-type 129Sv mice had the most pronounced intimal hyperplasia, the C57Bl/6 mice the least, and the mixed strain an intermediate amount ( Table 3 ). The ␤ 3 Ϫ/Ϫ mice are of mixed lineage, and so they were compared with the mixed-lineage wild-type mice. The P-selectinϪ/Ϫ mice have a C57Bl/6 background, and so they were compared with the wild-type C57Bl/6 mice.
The wild-type mixed C57/129Sv ␤ 3 ϩ/ϩ and ␤ 3 Ϫ/Ϫ mice demonstrated similar levels of neointimal growth as judged by neointimal area, intima/media ratios, and residual luminal area (Figure 4 ). In sharp contrast, the P-selectinϪ/Ϫ mice had significantly less neointimal growth than the wild-type C57Bl/6 mice (Pϭ0.075 for intimal area, Pϭ0.003 for intima/media ratio, and Pϭ0.052 for luminal area; Figure 4 ).
Discussion
Using a model of transluminal endothelial injury designed to simulate the vascular injury induced by percutaneous coronary interventions in humans, we observed that ␤ 3 -integrindeficient mice were not protected from developing intimal hyperplasia. In sharp contrast, and in accord with studies using different forms of vascular injury, 12,13 P-selectindeficient mice were protected from developing intimal hy- perplasia. Our findings in the ␤ 3 Ϫ/Ϫ mice stand in stark contrast to a large body of data indicating that antagonists of integrin ␣ V ␤ 3 (and, in some cases, ␣ IIb ␤ 3 ) reduce intimal hyperplasia after vascular injury in other animal models (Table 1) . A number of factors may account for the apparent discrepancy between our results and those obtained using inhibitors to ␣ V ␤ 3 (and, in some cases, ␣ IIb ␤ 3 ). First, differences in animal species and/or technical features of the models may influence the contribution of ␤ 3 -integrins to intimal hyperplasia. Previous models have involved balloon catheter injury induced in rabbits, rats, and guinea pigs; catheter injury in hamsters; stent implantation in pigs, monkeys, and baboons; and arterial cuff injury in rabbits (Table  1) . In contrast to these models, our model utilizes mice and involves a combination of guidewire-induced endothelial denudation and arterial ligation; the latter maneuver, which is known to enhance or produce intimal hyperplasia in other models, 20 was not used in the previous studies using antagonist to ␣ V ␤ 3 . Nonetheless, the protection from intimal hyperplasia we observed with the P-selectinϪ/Ϫ mice is very similar to that obtained both in a mouse model utilizing arterial ligation to initiate vascular injury 12 and in a rat model involving balloon catheter injury. 13 Second, loss of ␣ V ␤ 3 on a genetic basis may result in compensatory increases in the number and/or affinity of other adhesion receptors, whereas such compensation probably cannot occur with acute inhibition of ␣ V ␤ 3 . For example, we previously demonstrated that Glanzmann thrombasthenia patients with abnormalities in ␣ IIb had increased numbers of platelet ␣ V ␤ 3 receptors. 21 In addition, in contrast to the effect of inhibiting an integrin receptor, the absence of the receptor may affect signaling mediated by other integrins by virtue of decreased binding of intracellular proteins involved in signaling that ordinarily bind to the cytoplasmic domain of the missing integrin. 22 Finally, as opposed to inhibiting the ␣ V ␤ 3 receptor, its absence in ␤ 3 Ϫ/Ϫ mice may result in the loss of transduction of signals initiated by ␣ V ␤ 3 ; such signals may be initiated by the unliganded receptor, the liganded receptor, or the antagonized receptor.
In sharp contrast to the failure of ␤ 3 -integrin deficiency to protect against the development of intimal hyperplasia after vascular injury, P-selectin deficiency offered dramatic protection. Because this protection correlated with nearly complete absence of leukocyte recruitment to the platelets lining the vessel 1 hour after injury, it is possible that leukocyte recruitment is a crucial element in the development of intimal hyperplasia. However, the platelets that deposited on the damaged blood vessel wall of the P-selectinϪ/Ϫ mice were less compact and retained more of their granular contents than the platelets that deposited on the blood vessel surface of wild-type mice, which suggests that the platelets may be less activated. Our observations on platelet thrombus formation in P-selectinϪ/Ϫ mice are consistent with several other observations that indicate that P-selectin plays an important role in platelet function. Thus, P-selectinϪ/Ϫ mice have prolonged bleeding times, 23 and P-selectin has been implicated in contributing to both platelet-platelet interactions in vitro 24 and fibrin thrombus formation in vivo. 25 Moreover, Ruggeri et al 26 presented evidence that platelet thrombi formed from P-selectinϪ/Ϫ mice on collagen-coated surfaces ex vivo under shear are taller and thinner than thrombi formed from wild-type mice. These results are very similar to our in vivo data. Recently, P-selectin glycoprotein ligand-1 (PSGL-1) was detected on platelets, 27 and the platelet GP Ib/IX/V complex has been identified as a counterreceptor for endothelial P-selectin, 28 which raises the possibility that activated platelets expressing P-selectin can interact with activated and unactivated platelets via GP Ib/IX/V and/or PSGL-1. Such interactions may contribute to platelet accumulation, platelet activation, and platelet thrombus formation. Thus, it remains possible that at least some of the protection from the development of intimal hyperplasia in P-selectinϪ/Ϫ mice reflects abnormalities in platelet function rather than abnormal leukocyte recruitment. Nonetheless, a correlation between early leukocyte recruitment and subsequent develop-ment of intimal hyperplasia has previously been observed by several investigators using other species, 29 -33 and studies by Simon et al 34 recently demonstrated that ␣ M ␤ 2 -deficient mice (Mac1Ϫ/Ϫ) were protected from developing intimal hyperplasia after vascular injury. There are a number of plausible links between leukocyte recruitment and subsequent development of intimal hyperplasia, 31 including direct involvement of macrophages and activation of smooth muscle cells by leukocyte elastase, 10 but causality between these phenomena and the mechanisms responsible remain to be established. Immunohistochemical analysis revealed that platelets were deposited along the vessels in both wild-type and ␤ 3 -integrindeficient mice, and TEM demonstrated a single layer of platelets in the ␤ 3 Ϫ/Ϫ mice, which indicates that platelet adhesion but not platelet-platelet interactions occur in the absence of ␣ IIb ␤ 3 , presumably via receptors such as GP Ib. ␤ 3 Ϫ/Ϫ mice recruited leukocytes to the platelets adherent to the site of vascular injury at 1 hour, but P-selectinϪ/Ϫ mice did not. Several receptor pairs have been implicated in platelet-leukocyte interactions 4 : P-selectin on the surface of 
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activated platelets and its leukocyte counterreceptor PSGL-1; platelet GP Ib and leukocyte ␣ M ␤ 2 ; platelet intercellular adhesion molecule-2 and leukocyte ␣ L ␤ 2 ; platelet ␣ IIb ␤ 3 and/or ␣ V ␤ 3 bridged by fibrinogen to leukocyte ␣ M ␤ 2 ; and platelet and leukocyte CD36 (GP IV) bridged by thrombospondin-1. Our results indicate that neither ␣ IIb ␤ 3 nor ␣ V ␤ 3 is necessary for murine platelet-leukocyte interactions but that P-selectin expression is required. In unpublished studies, we have confirmed that as in humans, murine platelet P-selectin plays a major role in platelet-leukocyte interactions, because antibodies to P-selectin inhibit the binding of murine neutrophils to thrombin-activated murine platelets in vitro (V. Evangelista, MD, S.S. Smyth, MD, PhD, and B.S. Coller, MD, unpublished data, 1999).
In summary, the present study provides evidence that ␤ 3 -integrin deficiency results in decreased platelet deposition but no protection from intimal hyperplasia, whereas P-selectin deficiency protects against the development of intimal hyperplasia. Because antagonists of ␣ IIb ␤ 3 have demonstrated efficacy in preventing acute ischemic complications of percutaneous coronary interventions, 35 our data are of potential therapeutic importance, raising the possibility that the addition of an antagonist to P-selectin may provide additional protection against intimal hyperplasia and clinical restenosis.
Note Added in Proof
After acceptance of this manuscript, Chico et al (Circulation. 2001;103:1135-1141) reported that antagonists to ␣ IIb ␤ 3 , ␣ V ␤ 3 , or both ␣ IIb ␤ 3 and ␣ V ␤ 3 prevented neointima formation after porcine coronary artery angioplasty when administered for 14 days. 
